Officials Visit Shenzhen True Flavor Biotech for Industry Research

Aug.08.2022
Officials Visit Shenzhen True Flavor Biotech for Industry Research
Shenzhen officials visit Shenzhen Zhenwei Bioscience to discuss their development plans and commend their innovative progress.

On August 4th, a delegation led by Cai Ying, Secretary of the Guangming District Committee in Shenzhen, including Shen Huaxin and Zhang Feng, both members of the District Committee, visited Shenzhen Truly Bio-Tech Co., Ltd. They were accompanied by Peng Hua, Deputy Director of the District Committee and Government Office, Lin Shuping, Director of the District Industrial and Information Bureau, Liu Kun, Secretary of the Yutang Street Party Working Committee, Liu Li, Deputy Director of the District Investment Promotion Service Center, and Zeng Peisheng, Deputy Director of the Guangming District Tobacco Monopoly Bureau. The general manager of Truly Bio-Tech, Zou Yang, and other members of management welcomed and hosted the delegation.


A research team conducted a site visit to the offices of Truly Flavored Biotech and received a detailed explanation from the company's leader on various aspects of the company's functional centers, including the introduction of top research equipment, the standardization of process systems, the improvement of talent, and the upgrading of industry intelligence. The team also observed the operation of the Aerosol Technology Research Institute, the pharmaceutical-grade GMP cleanroom, the quality control center, and the fragrance development center, gaining a thorough understanding of the current state of technology personnel, hardware and software facilities, and product development progress. The team engaged in in-depth discussions with staff members and gained a comprehensive understanding of the processes involved in raw material selection, quality testing, and new product research and development. The team fully recognized Truly Flavored Biotech's efforts to "promote innovation-led industry and drive development with scientific research" as a benchmark, a growth booster, and a long-term strategy.


After the visit, a symposium was held under the chairmanship of the Huanxin Executive Committee of the research group.


During the symposium, Secretary Cai Ying fully recognized the work of Zhenwei Biology. She pointed out that as a leading company in the electronic atomized liquid industry, Zhenwei Biology not only has a strong development momentum, but also actively undertakes corporate social responsibility. The company is also forward-thinking in research and innovation, market judgment, and new enterprise layout. At the same time, Secretary Cai Ying expressed deep concern for the company's future development plan. She hopes that Zhenwei Biology will further improve its industrial layout, seize opportunities for further development and expansion, and integrate into the overall development of the Guangming Science City. Meanwhile, the government and various departments of Guangming District will continue to implement pro-enterprise and supportive policies, providing top-notch services and quality space for long-term development and stability of enterprises. The government aims to maintain the vitality of the market, job security, and the welfare of the people in promoting the steady and progressive development of the local economy.


During the meeting, the research team listened to a report from Mr. Zou Yang, the General Manager of Zhenwei Biotech, on the progress and achievements of the company's phase work and the strategic planning for future development. Mr. Zou focused on the current national policies for the electronic atomized liquid industry, Zhenwei's development of new products in compliance with national standards, and the company's economic growth in the first half of the year. He stated that with the help of preferential policies from the government and various departments in Guangming District, Zhenwei Biotech's economic growth has been rapidly increasing since the first half of 2022. Furthermore, in order to better implement industry policy requirements, Zhenwei Biotech established the Zhenwei Biotech (Yunnan) Research Institute immediately after obtaining the tobacco monopoly production license, and is fully engaged in the research of tobacco-flavored atomized products. Zhenwei Biotech hopes to cooperate with the industry's upstream and downstream industries to create electronic atomized products with international influence.


The General Manager, Zou Yang, also stated that Zhenwei Biology will establish itself in Guangming, adhere to the real economy, persist in innovation, elevate its standards, strive to improve the company's efficiency and size, and firmly uphold the industry mission of "being a role model, setting an example, and leading the way." With a foundation in the electronic atomization liquid industry, they will develop in multiple modes, channels, and diversify cooperation, continuously improve market confidence with new development and achievements, make greater contributions to socio-economic development, and also hope that Zhenwei Biology will rely on its strong scientific research capabilities to make a positive contribution to the economic development of Guangming district.


The visit by district leaders is a strong recognition of the achievements in our company's development. In the future, Zhenwei Biological will proactively embrace regulation, adhere to industry policy requirements and government calls, increase research and development investment, and persist in pursuing high-quality development. We will contribute to the economic development of Guangming District and create a win-win outcome.


This article contains excerpts or reprints from third-party sources whose copyrights belong to the original media and authors. If there is any infringement, please contact us for deletion. Any individual or organization that wants to reprint this content should contact the author and refrain from direct reposting.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | DOJO Launches 0+6ml BLAST7K Fresh in UK in September, Retaining 2+8ml Pod Compatibility Ahead of October Per-Milliliter Vaping Duty
Product | DOJO Launches 0+6ml BLAST7K Fresh in UK in September, Retaining 2+8ml Pod Compatibility Ahead of October Per-Milliliter Vaping Duty
DOJO officially launched the BLAST7K Fresh on September 17, 2026, introducing a UK-market prefilled pod product with 6ml of e-liquid and a manufacturer-rated capacity of up to 7,000 puffs. The device features a 1000mAh rechargeable battery, the INSTA-JUICED structure and COREX BLAST dual-mesh technology, while retaining compatibility with existing BLAST pods. The launch comes less than two weeks before the UK's Vaping Products Duty takes effect on October 1. At the new duty rate, 6ml of vaping liquid would correspond to £1.32 in VPD. DOJO has not stated that the product's 6ml format was designed in response to the new duty.
Sep.20
UK Vape Tax Countdown: Retailer Vape HQ Estimates 100ml E-liquid Prices Could Rise From £12.99 to £39.39, While Pod Kits Increase Less Than 10%
UK Vape Tax Countdown: Retailer Vape HQ Estimates 100ml E-liquid Prices Could Rise From £12.99 to £39.39, While Pod Kits Increase Less Than 10%
The UK’s Vaping Products Duty (VPD), scheduled to take effect in October 2026, is prompting retailers to assess how different vape categories may be affected. UK retailer Vape HQ has estimated potential price changes under the new volume-based tax system, showing that 100ml shortfill e-liquids could see prices rise from around £12.99 to £39.39, a 203% increase, while 2ml prefilled pod vape kits could rise from £5.99 to £6.52, an increase of about 9%. The estimates highlight how a volume-based tax structure creates uneven cost impacts across product categories.
Aug.19
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
Private antitrust litigation stemming from Altria's 2018 $12.8 billion investment for a 35% economic interest in JUUL is advancing before the U.S. Court of Appeals for the Ninth Circuit. Direct purchasers, indirect purchasers and indirect resellers of JUUL products filed answering briefs this week seeking to preserve class certifications granted by a California federal court in February. Altria and JUUL argue that individual consumers and large distributors differ too much in purchasing terms to remain in a single direct-purchaser class, while a separate dispute concerns whether California antitrust law can apply to indirect purchasers across 27 jurisdictions. A September trial has been put on hold during the appeal.
Sep.23
2Firsts Data | China’s Vape-Related Exports Rise 16.5% in July 2026 as U.S.-Bound Shipments Jump 53.5%
2Firsts Data | China’s Vape-Related Exports Rise 16.5% in July 2026 as U.S.-Bound Shipments Jump 53.5%
China’s vape-related exports reached $1.047 billion in July 2026, up 16.5% year on year and the highest monthly total of the year. Growth was heavily concentrated in the U.S., where exports jumped 53.5% to $404 million and accounted for 94.9% of the overall increase. Exports to all other markets rose just 1.2%. By category, nicotine-containing non-combustible products—primarily vapes—under HS24041200 rose 24.7% and generated 95.5% of the total increase. Vape-device exports under HS85434000 fell 0.4%, while other nicotine-substitute products under HS24041990 grew 88.9% but remained comparatively small.
DATA
Aug.24
UK Vape Maker Riot Enters Clacton By-Election to Fight Government 'White Packaging' Proposals
UK Vape Maker Riot Enters Clacton By-Election to Fight Government 'White Packaging' Proposals
British e-liquid manufacturer Riot Labs has introduced a fictional “candidate” called Riot Man around the Clacton parliamentary by-election, seeking to mobilize consumers and retailers against parts of the UK government’s proposed restrictions on vape packaging, device appearance and retail displays. Riot Man is not listed as an official candidate.
Aug.12
Product | Philip Morris Korea Launches TEREA Limona Pearl, Expanding Fresh Blend Capsule Lineup to Five
Product | Philip Morris Korea Launches TEREA Limona Pearl, Expanding Fresh Blend Capsule Lineup to Five
Philip Morris Korea launched TEREA Limona Pearl in South Korea on August 31, 2026, expanding the TEREA Fresh Blend capsule tobacco stick lineup from four variants to five. Designed for the IQOS ILUMA series, the new stick combines a capsule with what the company calls a Fresh Filter. Philip Morris Korea describes the product as offering an aromatic, refreshing flavor profile with a cooling sensation, with an additional fresh note released when the capsule is crushed. The recommended retail price is KRW 4,800 per pack, with sales through IQOS stores and convenience stores nationwide. No reliable evidence has been found that the same Limona Pearl SKU was previously officially launched in another major IQOS market.
Sep.01